Supporting Sustainable Implementation of HIV and TB Services for Epidemic Control in The Republic of Mozambique under the President’s Emergency Plan for AIDS Relief (PEPFAR) | CDC RFA GH16 163402CONT17

Opportunity Information: Apply for CDC RFA GH16 163402CONT17

This grant opportunity, titled "Supporting Sustainable Implementation of HIV and TB Services for Epidemic Control in the Republic of Mozambique under the President's Emergency Plan for AIDS Relief (PEPFAR)," is a continuation funding announcement issued by the U.S. Centers for Disease Control and Prevention (CDC) through its Center for Global Health (CGH). The program sits within a public health focus area and is tied to the longstanding PEPFAR initiative, which supports country-led efforts to control and ultimately end the HIV epidemic, while also addressing the closely linked burden of tuberculosis (TB), including HIV/TB co-infection. The purpose of this continuation is to sustain and advance ongoing HIV and TB service delivery and implementation work already underway in Mozambique, rather than to launch brand-new projects or bring in new organizations.

A key point in this notice is that it is explicitly limited to organizations that previously received awards under the earlier funding opportunity CDC-RFA-GH16-1634. In other words, this is not an open competition. It is structured as continuation funding, meaning the CDC is extending financial support to existing grantees so they can keep executing approved activities, maintain program continuity, and preserve progress toward epidemic control goals. The eligible applicant category is listed as "Others," but the narrative clarification makes the practical eligibility very narrow: only prior awardees under the referenced predecessor announcement can be considered for these continuation awards.

From an administrative standpoint, the funding instrument is a Cooperative Agreement, which generally indicates substantial involvement by the CDC in program implementation beyond what is typical in a standard grant. Cooperative agreements often involve ongoing technical collaboration, oversight, and shared responsibility for achieving program outcomes. This type of arrangement is common for large-scale public health implementation efforts, especially those requiring strong alignment with national strategies, coordinated partner networks, performance monitoring, and continuous quality improvement.

The opportunity is categorized under Health and aligned to CFDA number 93.067, which corresponds to CDC global health activities and provides a standardized reference for the federal assistance program area. The opportunity number is CDC RFA GH16 163402CONT17, signaling it is a continuation (CONT) linked back to the original GH16-1634 award. The original closing date for this continuation notice is listed as April 7, 2017, and the posting (creation) date is February 2, 2017. The announcement anticipates up to 10 awards, which suggests that multiple existing implementing partners in Mozambique were expected to receive continued support under this mechanism.

Notably, the award ceiling is listed as 0, which typically means the ceiling amount is not specified in the public summary or is determined through internal allocation decisions tied to prior awards, available appropriations, and approved continuation budgets. In continuation funding contexts, the amount is often based on previously negotiated budgets, annual workplan approvals, and performance considerations rather than a single published maximum.

In practical terms, the grant centers on sustaining implementation of HIV and TB services aimed at epidemic control in Mozambique. While the brief summary does not list specific activities, efforts under PEPFAR and CDC cooperative agreements in similar contexts commonly include strengthening HIV testing services and linkage to treatment, improving antiretroviral therapy (ART) initiation and retention, enhancing viral load monitoring and suppression, integrating TB screening and prevention into HIV services, improving TB case detection and treatment outcomes, and reinforcing data systems, surveillance, and quality management. The "sustainable implementation" framing also typically implies building the capacity of Mozambique's health system and local institutions, supporting the Ministry of Health and provincial/district structures, and improving long-term program performance through workforce development and stronger monitoring and evaluation.

Overall, this opportunity is best understood as a targeted, administrative continuation that keeps existing CDC/PEPFAR HIV and TB investments in Mozambique moving forward through established partners, using a cooperative agreement model that emphasizes close technical collaboration with CDC to achieve measurable public health impact.

• The Centers for Disease Control - CGH in the health sector is offering a public funding opportunity titled "Supporting Sustainable Implementation of HIV and TB Services for Epidemic Control in The Republic of Mozambique under the President’s Emergency Plan for AIDS Relief (PEPFAR)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067.
• This funding opportunity was created on 2017-02-02.
• Applicants must submit their applications by 2017-04-07. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• The number of recipients for this funding is limited to 10 candidate(s).
• Eligible applicants include: Others.

Apply for CDC RFA GH16 163402CONT17

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: